Transition of lupus erythematosus tumidus to systemic lupus erythematosus - case report and literature review

被引:0
作者
Burmann, Sven [1 ]
Bertling, Frederik [2 ]
Kreuter, Alexander [1 ]
机构
[1] Helios St Elisabeth Klin Oberhausen, Klin Dermatol Venerol & Allergol, Oberhausen, Germany
[2] Pathol Rhein Ruhr, Mulheim An Der Ruhr, Germany
关键词
Lupus erythematosus tumidus; transition to systemic lupus erythematosus; anifrolumab therapy; B-CELL DEPLETION;
D O I
10.1055/a-2517-5956
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The transition of lupus erythematosus tumidus (LET) to systemic lupus erythematosus (SLE) is a rarity. We report the case of a 63-year-old female patient who presented to our dermatology outpatient clinic with a previously known LET and new skin lesions on the lower extremities. Serologic examinations showed a transition from ANA negativity to positive values, accompanied by elevated anti-dsDNA antibodies and decreased complement factors, thus fulfilling the criteria for SLE. In the present case, which was particularly challenging due to the extended treatment history and additional diseases, treatment with anifrolumab was chosen due to the progressive systemic clinical picture, in order to specifically control disease activity and suppress systemic manifestations. This case illustrates the importance of close follow-up of patients with LET, especially in the presence of risk factors, in order to identify a potential transition to SLE at an early stage and to take timely therapeutic measures.
引用
收藏
页码:78 / 82
页数:5
相关论文
共 16 条
[1]   Advances in the Pathogenesis and Treatment of Systemic Lupus Erythematosus [J].
Accapezzato, Daniele ;
Caccavale, Rosalba ;
Paroli, Maria Pia ;
Gioia, Chiara ;
Nguyen, Bich Lien ;
Spadea, Luca ;
Paroli, Marino .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
[2]  
Aringer M, 2019, ARTHRITIS RHEUMATOL, V71, P1400, DOI [10.1002/art.40930, 10.1136/annrheumdis-2018-214819]
[3]   Rowell's syndrome: a rare but distinct entity in rheumatology [J].
Chandra, Atanu ;
Saha, Swarup Kanta ;
Ray, Aritra Kumar ;
Karmakar, Parthasarathi .
BMJ CASE REPORTS, 2020, 13 (09)
[4]   Long-Term Safety and Efficacy of Anifrolumab in Adults With Systemic Lupus Erythematosus: Results of a Phase II Open-Label Extension Study [J].
Chatham, W. Winn ;
Furie, Richard ;
Saxena, Amit ;
Brohawn, Philip ;
Schwetje, Erik ;
Abreu, Gabriel ;
Tummala, Raj .
ARTHRITIS & RHEUMATOLOGY, 2021, 73 (05) :837-847
[5]   A Systematic Review of the Progression of Cutaneous Lupus to Systemic Lupus Erythematosus [J].
Curtiss, Paul ;
Walker, Amanda M. ;
Chong, Benjamin F. .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[6]  
Deutsche Gesellschaft fur Rheumatologie e.V, 2017, AWMF-Registernummer 060-004
[7]   Real-world burden of systemic lupus erythematosus in the USA: a comparative cohort study from the Medical Expenditure Panel Survey (MEPS) 2016-2018 [J].
Grabich, Shannon ;
Farrelly, Eileen ;
Ortmann, Robert ;
Pollack, Michael ;
Wu, Sandra Sze-Jung .
LUPUS SCIENCE & MEDICINE, 2022, 9 (01)
[8]   Predominant role of plasmacytoid dendritic cells in stimulating systemic autoimmunity [J].
Huang, Xinfang ;
Dorta-Estremera, Stephanie ;
Yao, Yihong ;
Shen, Nan ;
Cao, Wei .
FRONTIERS IN IMMUNOLOGY, 2015, 6
[9]   Systemic Lupus Erythematosus: New Diagnostic and Therapeutic Approaches [J].
Lazar, Stephanie ;
Kahlenberg, J. Michelle .
ANNUAL REVIEW OF MEDICINE, 2023, 74 :339-352
[10]   B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients [J].
Leandro, MJ ;
Cambridge, G ;
Edwards, JC ;
Ehrenstein, MR ;
Isenberg, DA .
RHEUMATOLOGY, 2005, 44 (12) :1542-1545